Marwan Ghabril1, Naga Chalasani, Einar Björnsson. 1. Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Abstract
PURPOSE OF REVIEW: To gather new and important data published on idiosyncratic drug-induced liver injury (DILI) over the past 2 years in the peer-reviewed literature. Clinical studies focusing on mechanisms of injury, clinical evaluation and prognosis will be reviewed. RECENT FINDINGS: The most common drugs leading to DILI in the United States are antibiotics, central nervous system agents, herbal/dietary supplements and immunomodulatory agents. Hepatocellular type of DILI is more common in younger patients, whereas cholestatic pattern increases with older age. Certain human leukocyte antigen genotype increases the likelihood of flucloxacillin-induced liver injury. Idiosyncratic DILI was shown to have an important dose-dependency and drugs with extensive hepatic metabolism are associated with higher frequency of DILI. Chronic DILI may occur, but development of clinically important liver injury after severe DILI is rare. N-acetylcysteine seems to be beneficial for patients with acute liver failure caused by medications or herbal agents.
PURPOSE OF REVIEW: To gather new and important data published on idiosyncratic drug-induced liver injury (DILI) over the past 2 years in the peer-reviewed literature. Clinical studies focusing on mechanisms of injury, clinical evaluation and prognosis will be reviewed. RECENT FINDINGS: The most common drugs leading to DILI in the United States are antibiotics, central nervous system agents, herbal/dietary supplements and immunomodulatory agents. Hepatocellular type of DILI is more common in younger patients, whereas cholestatic pattern increases with older age. Certain human leukocyte antigen genotype increases the likelihood of flucloxacillin-induced liver injury. Idiosyncratic DILI was shown to have an important dose-dependency and drugs with extensive hepatic metabolism are associated with higher frequency of DILI. Chronic DILI may occur, but development of clinically important liver injury after severe DILI is rare. N-acetylcysteine seems to be beneficial for patients with acute liver failure caused by medications or herbal agents.
Authors: Allen D Brinker; Ronald T Wassel; Jenna Lyndly; Jose Serrano; Mark Avigan; William M Lee; Leonard B Seeff Journal: Hepatology Date: 2009-01 Impact factor: 17.425
Authors: Francisco J de Abajo; Dolores Montero; Mariano Madurga; Luis A García Rodríguez Journal: Br J Clin Pharmacol Date: 2004-07 Impact factor: 4.335
Authors: Ann K Daly; Peter T Donaldson; Pallav Bhatnagar; Yufeng Shen; Itsik Pe'er; Aris Floratos; Mark J Daly; David B Goldstein; Sally John; Matthew R Nelson; Julia Graham; B Kevin Park; John F Dillon; William Bernal; Heather J Cordell; Munir Pirmohamed; Guruprasad P Aithal; Christopher P Day Journal: Nat Genet Date: 2009-05-31 Impact factor: 38.330
Authors: Arianna Bassan; Vinicius M Alves; Alexander Amberg; Lennart T Anger; Scott Auerbach; Lisa Beilke; Andreas Bender; Mark T D Cronin; Kevin P Cross; Jui-Hua Hsieh; Nigel Greene; Raymond Kemper; Marlene T Kim; Moiz Mumtaz; Tobias Noeske; Manuela Pavan; Julia Pletz; Daniel P Russo; Yogesh Sabnis; Markus Schaefer; David T Szabo; Jean-Pierre Valentin; Joerg Wichard; Dominic Williams; David Woolley; Craig Zwickl; Glenn J Myatt Journal: Comput Toxicol Date: 2021-09-09
Authors: Manish Barman; Bassem Al Hariri; Abdul Rahman Mustafa; Naseem Ambra; Israa Amjed; Ahmad Eid Nazzal Alharafsheh; M N Illahi; S Hamuda; Mohamedali Gaafar; Muhammad Sharif Journal: Qatar Med J Date: 2022-07-07
Authors: Juan Ignacio Marin Zuluaga; Andres Eduardo Marin Castro; Juan Camilo Perez Cadavid; Juan Carlos Restrepo Gutierrez Journal: J Med Case Rep Date: 2013-07-26